Aridis Pharmaceuticals Inc (ARDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 417 | 19,647 | 1,082 | 1,213 | 399 |
| Gross Profit | 417 | 19,647 | 1,082 | 1,213 | 399 |
| Operating Expenses | 1,286 | 5,978 | 7,345 | 8,633 | 7,811 |
| Operating Income | -869 | 13,669 | -6,263 | -7,420 | -7,412 |
| Other Income | 786 | -1,525 | -553 | 1,033 | -827 |
| Pre-tax Income | -83 | 12,144 | -6,816 | -6,387 | -8,239 |
| Net Income Continuous | -83 | 12,144 | -6,816 | -6,387 | -8,239 |
| Net Income | $-83 | $12,144 | $-6,816 | $-6,387 | $-8,239 |
| EPS Basic Total Ops | 0.00 | 0.34 | -0.22 | -0.26 | -0.47 |
| EPS Basic Continuous Ops | 0.00 | 0.34 | -0.22 | -0.26 | -0.47 |
| EPS Diluted Total Ops | 0.00 | 0.33 | -0.22 | -0.26 | -0.47 |
| EPS Diluted Continuous Ops | 0.00 | 0.33 | -0.22 | -0.26 | -0.47 |
| EPS Diluted Before Non-Recurring Items | -0.02 | 0.33 | -0.22 | -0.27 | -0.42 |
| EBITDA(a) | $-810 | $13,732 | $-6,176 | $-7,320 | $-7,287 |